Imitrodast

CAS No. 114686-12-3

Imitrodast( —— )

Catalog No. M36182 CAS No. 114686-12-3

Imitrodast is a small molecule thromboxane A2 synthase (TXA2 synthase) inhibitor for the treatment of immune system disorders, respiratory disorders, and cardiovascular diseases, and can be used in studies of arterial thrombosis, asthma, and coronary vasospasm.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 319 Get Quote
5MG 513 Get Quote
10MG 740 Get Quote
25MG 1086 Get Quote
50MG 1490 Get Quote
100MG 1962 Get Quote
500MG 3933 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Imitrodast
  • Note
    Research use only, not for human use.
  • Brief Description
    Imitrodast is a small molecule thromboxane A2 synthase (TXA2 synthase) inhibitor for the treatment of immune system disorders, respiratory disorders, and cardiovascular diseases, and can be used in studies of arterial thrombosis, asthma, and coronary vasospasm.
  • Description
    Imitrodast is a small molecule thromboxane A2 synthase (TXA2 synthase) inhibitor for the treatment of immune system disorders, respiratory disorders, and cardiovascular diseases, and can be used in studies of arterial thrombosis, asthma, and coronary vasospasm.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Autophagy
  • Target
    Thrombin
  • Recptor
    Thrombin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    114686-12-3
  • Formula Weight
    260.31
  • Molecular Formula
    C13H12N2O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C=1SC2=C(C1)CCC(C(O)=O)=C2)N3C=CN=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Ximelagatran

    Ximelagatran, a direct thrombin inhibitor, can be taken orally and acts solely by inhibiting the actions of thrombin. Ximelagatran is converted to the active agent melagatran in vivo.

  • Efegatran sulfate

    Efegatran sulfate (LY294468 sulfate) is a potent thrombin inhibitor used in the treatment of thrombotic disorders.

  • Naroparcil

    Naroparcil, an orally available thioglycoside analog of 4-methylumbelliferyl β-D-xyloside, showed antithrombotic effects in the Wessler sludge model of venous thrombosis (jugular vein).